Fundraising Fox

Faze Medicines

Cambridge, US · Founded 2018 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

EF
Ed FreedmanNamed on SEC filing

Board

CPCary Pfeffer
Cary PfefferinBoard directorInvestor at Third Rock Ventures
RTRobert Tepper
Robert TepperinBoard directorPartner and co-founder of Third Rock Ventures
CHCharles Homcy
Charles HomcyBoard directorInvestor at Third Rock Ventures

Investors · 1

Third Rock Venturesreported · 2 sourcesBoston · $100K – $5Mvia Charles Homcy · board

Reported raises · per SEC filings

Form D private placements

$30.4M disclosed across 1 round · 2020

▶$30.4MraisedDec 2020 · 9 investors · Biotechnology
Rule 506(b)
Faze Medicines secures funding to study molecular condensates in ALSpadiracinnovation.org · Dec 2020
Officers, directors & promoters on the filing
  • Cary PfefferExecutive Officer, Director
  • Ed FreedmanExecutive Officer, Director
  • Robert TepperDirector
  • Charles HomcyDirector
Offering amount
$81M
Amount sold
$30.4M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Faze Medicines secures funding to study molecular condensates in ALSpadiracinnovation.org · Dec 2020

Frequently asked questions

Who are Faze Medicines's investors?
Faze Medicines's investors include Third Rock Ventures.
How much funding has Faze Medicines raised?
Faze Medicines has disclosed $30.4M raised across 1 round.
Where is Faze Medicines headquartered?
Faze Medicines is headquartered in Cambridge, US.